Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2020-10-26 Investor Presentation
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
The presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2020 to be made to analysts is enclosed for your records.
Investor Presentation Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) and mentions a presentation to analysts on unaudited consolidated financial results for the quarter and half year ended 30th September 2020. It includes summary revenue data for Q2 FY21 and H1 FY21 compared to the previous year. The document is relatively short (2044 characters) and is described as a presentation to analysts, not the full financial report itself. This matches the definition of an Investor Presentation (IP), which is a detailed presentation for investors focusing on financials, strategy, and market position. It is not an earnings release (ER) because it includes a presentation rather than just key highlights, and it is not an interim report (IR) because it does not contain full financial statements or substantive financial data and analysis. Therefore, the correct classification is Investor Presentation (IP).
2020-10-26 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding a presentation to analysts on unaudited consolidated financial results for the quarter and half year ended 30th September 2020. It includes summary revenue data for Q2 FY21 and H1 FY21 compared to prior periods. The document is relatively short (2044 characters) and is explicitly described as a presentation to analysts, not a full financial report. This matches the definition of an Investor Presentation (IP), which is a detailed presentation for investors focusing on financials, strategy, and market position. It is not an earnings release (ER) because it contains more detailed financial data and is presented as a presentation. It is not an interim report (IR) because it is a presentation, not a comprehensive report with full financial statements. Therefore, the correct classification is Investor Presentation (IP).
2020-10-26 English
We would like to inform that the Board has at its meeting held today approved, inter-alia, the Audited Standalone Financial Results along with audit report thereon and Unaudited Consolidated ....
Interim / Quarterly Report Classification · 100% confidence The document is an Independent Auditor's Report on the quarterly standalone financial results and standalone year-to-date results of Torrent Pharmaceuticals Limited for the quarter ended 30 September 2020 and the half year ended 30 September 2020. It references Regulation 33 and Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertain to interim financial reporting. The report includes detailed financial statements, notes, and auditor's opinion on the financial results. The presence of detailed financial data and the audit opinion on quarterly and half-year results clearly identifies this as an Interim / Quarterly Report. It is not a full Annual Report (10-K), nor is it merely an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2021
2020-10-26 English
Financial Result Updates
Regulatory Filings
2020-10-26 English
Loss of Share Certificates
Transaction in Own Shares Classification · 75% confidence The document is a formal letter dated 16th October 2020 from Torrent Pharmaceuticals Limited addressed to BSE Limited. It informs about the issuance of duplicate share certificates pursuant to SEBI regulations. The content is about share certificate issuance details, not about financial results, management changes, or regulatory filings of financial nature. The document is short (1689 characters) and is an announcement of a corporate action related to shares. This fits the category of Transaction in Own Shares (POS) as it relates to share certificates, but since it is about duplicate share certificates (replacement of lost or damaged certificates) rather than buyback or issuance of new shares, it is more aligned with a regulatory announcement about share certificates. However, none of the other categories fit better. The closest specific category is Transaction in Own Shares (POS), which includes share repurchase/issuance and related share transactions. Therefore, the best classification is POS with moderate confidence due to the nature of the document being about share certificates.
2020-10-16 English
Intimation of Issue of Duplicate Share Certificate
Share Issue/Capital Change Classification · 95% confidence The document is a letter dated 16th October 2020 from Torrent Pharmaceuticals Limited addressed to BSE Limited and NSE, informing about the issuance of duplicate share certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is about a specific administrative action related to share certificates, not a financial report, earnings release, or management discussion. The document length is short (1689 characters) and it is an announcement of a corporate action regarding shares. This fits best under the category of Share Issue/Capital Change (SHA), which includes announcements regarding share certificates and capital changes. It is not a report or a regulatory filing of a different nature, nor is it a director's dealing or major shareholding notification. Therefore, the classification is SHA with high confidence.
2020-10-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.